Abstract

Risk Management Plan Issued for Erythropoietin; U.S.–European Agreement to Reduce Burden of Orphan Drug Documentation; New Product Approvals from FDA; FDA, NIH Form Partnership to Improve Regulation

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call